Gene · 92
Papers1,751
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,751
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Diagnostic Gene-Expression Signature in Fibroblasts of Amyotrophic Lateral Sclerosis. | Cells | 2023 | 37508548 | PubTator, text mining | PubMed |
| Small Leucine-Rich Proteoglycan PODNL1 Identified as a Potential Tumor Matrix-Mediated Biomarker for Prognosis and Immunotherapy in a Pan-Cancer Setting. | Curr Issues Mol Biol | 2023 | 37504302 | PubTator, text mining | PubMed |
| N6-methyladenosine RNA modification: an emerging molecule in type 2 diabetes metabolism. | Front Endocrinol (Lausanne) | 2023 | 37484964 | PubTator, text mining | PubMed |
| Evaluation of somatic mutations in cervicovaginal samples as a non-invasive method for the detection and molecular classification of endometrial cancer. | EBioMedicine | 2023 | 37480623 | PubTator, text mining | PubMed |
| Activin receptor-like kinase 3: a critical modulator of development and function of mineralized tissues. | Front Cell Dev Biol | 2023 | 37457289 | PubTator, text mining | PubMed |
| TGF-β based risk model to predict the prognosis and immune features in glioblastoma. | Front Neurol | 2023 | 37456651 | PubTator, text mining | PubMed |
| Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management. | Front Endocrinol (Lausanne) | 2023 | 37455897 | PubTator, text mining | PubMed |
| Mutational signature dynamics shaping the evolution of oesophageal adenocarcinoma. | Nat Commun | 2023 | 37454136 | PubTator, text mining | PubMed |
| Integrated High-Throughput Bioinformatics (Microarray, RNA-Seq, and RNA Interaction) and qRT-PCR Investigation of BMPR1B Axis as a Potential Diagnostic Biomarker of Isfahan Breast Cancer. | Adv Biomed Res | 2023 | 37434942 | PubTator, text mining | PubMed |
| Circ_0001946 Promotes the Development of Acute Myeloid Leukemia by Upregulating PDL1 | Turk J Haematol | 2023 | 37431262 | PubTator, text mining | PubMed |
| Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failure. | Nat Commun | 2023 | 37429843 | PubTator, text mining | PubMed |
| SpatialDM for rapid identification of spatially co-expressed ligand-receptor and revealing cell-cell communication patterns. | Nat Commun | 2023 | 37414760 | PubTator, text mining | PubMed |
| Multiplex single-cell chemical genomics reveals the kinase dependence of the response to targeted therapy. | bioRxiv | 2023 | 37398090 | PubTator, text mining | PubMed |
| Dissecting the spermatogonial stem cell niche using spatial transcriptomics. | Cell Rep | 2023 | 37393620 | PubTator, text mining | PubMed |
| Recent developments on BMPs and their antagonists in inflammatory bowel diseases. | Cell Death Discov | 2023 | 37391444 | PubTator, text mining | PubMed |
| Activin A/ACVR2A axis inhibits epithelial-to-mesenchymal transition in colon cancer by activating SMAD2. | Mol Carcinog | 2023 | 37378449 | PubTator, text mining | PubMed |
| Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival. | Front Oncol | 2023 | 37377916 | PubTator, text mining | PubMed |
| Microsatellite Instability and Immune Response: From Microenvironment Features to Therapeutic Actionability-Lessons from Colorectal Cancer. | Genes (Basel) | 2023 | 37372349 | PubTator, text mining | PubMed |
| Feature Reviews of the Molecular Mechanisms of Nasopharyngeal Carcinoma. | Biomedicines | 2023 | 37371623 | PubTator, text mining | PubMed |
| Identification of PTPN20 as an innate immunity-related gene in gastric cancer with Helicobacter pylori infection. | Front Immunol | 2023 | 37359510 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92/papers?page=8